Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 4—April 2024
CME ACTIVITY - Synopsis

Concurrent Outbreaks of Hepatitis A, Invasive Meningococcal Disease, and Mpox, Florida, USA, 2021–2022

Timothy J. DoyleComments to Author , Megan Gumke, Danielle Stanek, Joshua Moore, Brian Buck, Timothy Locksmith, Kelly Tomson, Sarah Schmedes, George Churchwell, Shan Justin Hubsmith, Baskar Krishnamoorthy, Karalee Poschman, Brandi Danforth, Daniel Chacreton, and the outbreak investigation team1
Author affiliations: Florida Department of Health, Tallahassee, Florida, USA (T.J. Doyle, M. Gumke, D. Stanek, J. Moore, B. Buck, T. Locksmith, K. Thomson, S. Schmedes, G. Churchwell, S.J. Hubsmith, B. Krishnamoorthy, K. Poschman, B. Danforth, D. Chacreton); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (T.J. Doyle, K. Poschman)

Main Article

Table 1

Case definitions used in the investigation of concurrent outbreaks of hepatitis A, invasive meningococcal disease, and mpox, Florida, USA, 2021–2022*

Disease Definition
Hepatitis A
Inclusion criteria Florida residents meeting the surveillance case definition for hepatitis A† with symptom onset during November 1, 2021–November 30, 2022
Confirmed case A hepatitis A case with laboratory evidence of infection with HAV genotype IA, A17 cluster 21, or epidemiologically linked to a case with HAV A17 cluster 21 infection
Probable case A hepatitis A case who identified as transgender or MSM or had sexual contact with MSM, irrespective of other risk factors for hepatitis A
Suspected case A male hepatitis A case with unknown sexual history, and absence of other risk factors for hepatitis A (e.g., foreign travel, drug use, homelessness, incarceration)
Epidemiologically linked Household or sexual contact during the 15–50 d before symptom onset
Exclusions
Cases with sequencing results indicating infection with HAV other than genotype IA, A17 cluster 21
Invasive meningococcal disease
Inclusion criteria Florida residents meeting the surveillance case definition for invasive meningococcal disease† with symptom onset during November 1, 2021–November 30, 2022
Confirmed case An invasive meningococcal disease case who identifies as MSM or had sexual contact with MSM and evidence of serogroup C infection; or laboratory evidence of infection with ST11 CC11 serogroup C, with <100 SNPs difference to the outbreak strain, irrespective of sexual history
Probable case An invasive meningococcal disease case who identifies as MSM or had sexual contact with MSM and for whom no additional serogroup, ST, or CC typing is available; or who had evidence of serogroup C infection regardless of sexual history
Exclusions
Cases with sequencing results indicating infection with Neisseria meningitides other than ST11 CC11 serogroup C or with >100 SNP differences to the outbreak strain
Mpox
Inclusion criteria Florida residents meeting the surveillance case definition for confirmed or probable mpox‡ with symptom onset during May 1­–November 30, 2022

*CC, clonal complex; HAV, hepatitis A virus; MSM, men who have sex with men; SNP, single-nucleotide polymorphism; ST, sequence type; STI, sexually transmitted infection. †Per Florida Department of Health definition (15). ‡Per Centers for Disease Control and Prevention definition (16).

Main Article

References
  1. Cotter  SM, Sansom  S, Long  T, Koch  E, Kellerman  S, Smith  F, et al. Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J Infect Dis. 2003;187:123540. DOIPubMedGoogle Scholar
  2. Stene-Johansen  K, Tjon  G, Schreier  E, Bremer  V, Bruisten  S, Ngui  SL, et al. Molecular epidemiological studies show that hepatitis A virus is endemic among active homosexual men in Europe. J Med Virol. 2007;79:35665. DOIPubMedGoogle Scholar
  3. Ndumbi  P, Freidl  GS, Williams  CJ, Mårdh  O, Varela  C, Avellón  A, et al.; Members of the European Hepatitis A Outbreak Investigation Team. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area, June 2016 to May 2017. Euro Surveill. 2018;23:1700641. DOIPubMedGoogle Scholar
  4. Beebeejaun  K, Degala  S, Balogun  K, Simms  I, Woodhall  SC, Heinsbroek  E, et al. Outbreak of hepatitis A associated with men who have sex with men (MSM), England, July 2016 to January 2017. Euro Surveill. 2017;22:5. DOIPubMedGoogle Scholar
  5. Werber  D, Michaelis  K, Hausner  M, Sissolak  D, Wenzel  J, Bitzegeio  J, et al. Ongoing outbreaks of hepatitis A among men who have sex with men (MSM), Berlin, November 2016 to January 2017 - linked to other German cities and European countries. Euro Surveill. 2017;22:30457. DOIPubMedGoogle Scholar
  6. Foster  MA, Hofmeister  MG, Albertson  JP, Brown  KB, Burakoff  AW, Gandhi  AP, et al. Hepatitis A virus infections among men who have sex with men—eight U.S. states, 2017–2018. MMWR Morb Mortal Wkly Rep. 2021;70:8758. DOIPubMedGoogle Scholar
  7. Latash  J, Dorsinville  M, Del Rosso  P, Antwi  M, Reddy  V, Waechter  H, et al. Notes from the field: increase in reported hepatitis A infections among men who have sex with men—New York City, January–August 2017. MMWR Morb Mortal Wkly Rep. 2017;66:9991000. DOIPubMedGoogle Scholar
  8. Bozio  CH, Blain  A, MacNeil  J, Retchless  A, Weil  LM, Wang  X, et al. Meningococcal disease surveillance in men who have sex with men—United States, 2015–2016. MMWR Morb Mortal Wkly Rep. 2018;67:10603. DOIPubMedGoogle Scholar
  9. Taha  MK, Claus  H, Lappann  M, Veyrier  FJ, Otto  A, Becher  D, et al. Evolutionary events associated with an outbreak of meningococcal disease in men who have sex with men. PLoS One. 2016;11:e0154047. DOIPubMedGoogle Scholar
  10. Folaranmi  TA, Kretz  CB, Kamiya  H, MacNeil  JR, Whaley  MJ, Blain  A, et al. Increased risk for meningococcal disease among men who have sex with men in the United States, 2012–2015. Clin Infect Dis. 2017;65:75663. DOIPubMedGoogle Scholar
  11. Kava  CM, Rohraff  DM, Wallace  B, Mendoza-Alonzo  JL, Currie  DW, Munsey  AE, et al. Epidemiologic features of the monkeypox outbreak and the public health response—United States, May 17–October 6, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:144956. DOIPubMedGoogle Scholar
  12. Blackburn  D, Roth  NM, Gold  JAW, Pao  LZ, Olansky  E, Torrone  EA, et al. Epidemiologic and clinical features of mpox in transgender and gender-diverse adults—United States, May–November 2022. MMWR Morb Mortal Wkly Rep. 2022;71:16059. DOIPubMedGoogle Scholar
  13. Centers for Disease Control and Prevention. Mpox: 2022 U.S. map & case count [cited 2022 Dec 27]. https://www.cdc.gov/poxvirus/mpox/response/2022/us-map.html
  14. Florida Department of Health. Surveillance case definitions for reportable diseases in Florida [cited 2022 Nov 10]. https://www.floridahealth.gov/diseases-and-conditions/disease-reporting-and-management/disease-reporting-and-surveillance/_documents/surveillance-case-def-select-rd-fl.pdf
  15. Centers for Disease Control and Prevention. Case definitions for use in the 2022 monkeypox response [cited 2022 Nov 10]. https://www.cdc.gov/poxvirus/monkeypox/clinicians/case-definition.html
  16. Probert  WS, Gonzalez  C, Espinosa  A, Hacker  JK. Molecular genotyping of hepatitis A virus, California, USA, 2017–2018. Emerg Infect Dis. 2019;25:15946. DOIPubMedGoogle Scholar
  17. Ramachandran  S, Xia  GL, Dimitrova  Z, Lin  Y, Montgomery  M, Augustine  R, et al. Changing molecular epidemiology of hepatitis A virus infection, United States, 1996–2019. Emerg Infect Dis. 2021;27:17425. DOIPubMedGoogle Scholar
  18. Buono  SA, Kelly  RJ, Topaz  N, Retchless  AC, Silva  H, Chen  A, et al. Web-based genome analysis of bacterial meningitis pathogens for public health applications using the Bacterial Meningitis Genomic Analysis Platform (BMGAP). Front Genet. 2020;11:601870. DOIPubMedGoogle Scholar
  19. Minhaj  FS, Ogale  YP, Whitehill  F, Schultz  J, Foote  M, Davidson  W, et al.; Monkeypox Response Team 2022. Monkeypox Response Team 2022. Monkeypox outbreak—nine states, May 2022. MMWR Morb Mortal Wkly Rep. 2022;71:7649. DOIPubMedGoogle Scholar
  20. Li  Y, Olson  VA, Laue  T, Laker  MT, Damon  IK. Detection of monkeypox virus with real-time PCR assays. J Clin Virol. 2006;36:194203. DOIPubMedGoogle Scholar
  21. Li  Y, Zhao  H, Wilkins  K, Hughes  C, Damon  IK. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA. J Virol Methods. 2010;169:2237. DOIPubMedGoogle Scholar
  22. US Health and Human Services. HHS expanding monkeypox testing capacity to five commercial laboratory companies [cited 2022 Dec 27]. https://www.hhs.gov/about/news/2022/06/22/hhs-expanding-monkeypox-testing-capacity-five-commercial-laboratory-companies.html
  23. Gigante  CM, Korber  B, Seabolt  MH, Wilkins  K, Davidson  W, Rao  AK, et al. Multiple lineages of monkeypox virus detected in the United States, 2021-2022. Science. 2022;378:5605. DOIPubMedGoogle Scholar
  24. Centers for Disease Control and Prevention. Update on managing monkeypox in patients receiving therapeutics [cited 2022 Nov 17]. https://emergency.cdc.gov/han/2022/han00481.asp
  25. Saunders  KE, Van Horn  AN, Medlin  HK, Carpenter  A, Lee  PA, Gutierrez  L, et al. Monkeypox in a young infant—Florida, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:12201. DOIPubMedGoogle Scholar
  26. Hennessee  I, Shelus  V, McArdle  CE, Wolf  M, Schatzman  S, Carpenter  A, et al.; California Department of Public Health Monkeypox Pediatric Working Group; CDC Monkeypox Pediatric Working Group. CDC Monkeypox Pediatric Working Group. Epidemiologic and clinical features of children and adolescents aged <18 years with monkeypox—United States, May 17–September 24, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:140711. DOIPubMedGoogle Scholar
  27. Mendoza  R, Petras  JK, Jenkins  P, Gorensek  MJ, Mableson  S, Lee  PA, et al. Monkeypox virus infection resulting from an occupational needlestick—Florida, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:13489. DOIPubMedGoogle Scholar
  28. Hubach  RD, Owens  C. Findings on the monkeypox exposure mitigation strategies employed by men who have sex with men and transgender women in the United States. Arch Sex Behav. 2022;51:36538. DOIPubMedGoogle Scholar
  29. Delaney  KP, Sanchez  T, Hannah  M, Edwards  OW, Carpino  T, Agnew-Brune  C, et al. Strategies adopted by gay, bisexual, and other men who have sex with men to prevent monkeypox virus transmission—United States, August 2022. MMWR Morb Mortal Wkly Rep. 2022;71:112630. DOIPubMedGoogle Scholar
  30. Kriss  JL, Boersma  PM, Martin  E, Reed  K, Adjemian  J, Smith  N, et al. Receipt of first and second doses of JYNNEOS vaccine for prevention of monkeypox—United States, May 22–October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:13748. DOIPubMedGoogle Scholar
  31. Millman  AJ, Denson  DJ, Allen  ML, Malone  JA, Daskalakis  DC, Durrence  D, et al.; Atlanta Black Gay Pride Festival Monkeypox Response Team. A health equity approach for implementation of JYNNEOS vaccination at large, community-based LGBTQIA+ events—Georgia, August 27–September 5, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1382883. DOIPubMedGoogle Scholar
  32. Owens  LE, Currie  DW, Kramarow  EA, Siddique  S, Swanson  M, Carter  RJ, et al. JYNNEOS vaccination coverage among persons at risk for mpox—United States, May 22, 2022–January 31, 2023. MMWR Morb Mortal Wkly Rep. 2023;72:3427. DOIPubMedGoogle Scholar
  33. Mbaeyi  SA, Bozio  CH, Duffy  J, Rubin  LG, Hariri  S, Stephens  DS, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69:141. DOIPubMedGoogle Scholar
  34. Nelson  NP, Weng  MK, Hofmeister  MG, Moore  KL, Doshani  M, Kamili  S, et al. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep. 2020;69:138. DOIPubMedGoogle Scholar
  35. Daskalakis  D, Romanik  N, Jha  AK. Lessons from the mpox response. JAMA. 2024;331:3878; Epub ahead of print. DOIPubMedGoogle Scholar
  36. Lin  KY, Chen  GJ, Lee  YL, Huang  YC, Cheng  A, Sun  HY, et al. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review. World J Gastroenterol. 2017;23:3589606. DOIPubMedGoogle Scholar
  37. Singer  M, Bulled  N, Ostrach  B, Mendenhall  E. Syndemics and the biosocial conception of health. Lancet. 2017;389:94150. DOIPubMedGoogle Scholar
  38. Tsai  AC, Mendenhall  E, Trostle  JA, Kawachi  I. Co-occurring epidemics, syndemics, and population health. Lancet. 2017;389:97882. DOIPubMedGoogle Scholar
  39. Oprea  C, Ionuț Popa , Ianache  I, Păun  A, Vasile  S, Grațiela Țârdei , et al. Monkeypox, severe hepatitis A, and syphilis in an HIV returning traveler from Spain to Romania. Travel Med Infect Dis. 2022;50:102455. DOIPubMedGoogle Scholar
  40. Friesema  IH, Sonder  GJ, Petrignani  MW, Meiberg  AE, van Rijckevorsel  GG, Ruijs  WL, et al. Spillover of a hepatitis A outbreak among men who have sex with men (MSM) to the general population, the Netherlands, 2017. Euro Surveill. 2018;23:1800265. DOIPubMedGoogle Scholar
  41. Vaughan  G, Goncalves Rossi  LM, Forbi  JC, de Paula  VS, Purdy  MA, Xia  G, et al. Hepatitis A virus: host interactions, molecular epidemiology and evolution. Infect Genet Evol. 2014;21:22743. DOIPubMedGoogle Scholar

Main Article

1Members of the team are listed at the end of the article.

Page created: February 06, 2024
Page updated: March 18, 2024
Page reviewed: March 18, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external